Moffitt Cancer Center President and CEO, @MoffittNews. Tumor immunologist. Inspired leader. Girl dad. #DocsWhoRock. Driven to save more lives from #cancer.
Tampa, FL
- Tweets 6,031
- Following 2,217
- Followers 27,013
- Likes 33,902
#ScienceSaturday
❓ Why do T cells sometimes fail to fight cancer?
➡️ A new study in Nature shows that when T cells are exposed to cancer or long-term infections, they can enter a state called exhaustion, where they lose their ability to eliminate harmful cells.
➡️ The researchers found that exhausted T cells develop a special type of stress response. Instead of reducing protein production, these cells increase it, leading to protein buildup and overworked “chaperone” proteins. This stress weakens the T cells and helps tumors evade the immune system.
➡️ By blocking certain stress-related proteins, the scientists were able to restore T cell activity and improve the effectiveness of cancer immunotherapy in preclinical models.
🌟 Congratulations to my good friend and senior author Zihai Li of The Ohio State University Comprehensive Cancer Center and collaborators at Johns Hopkins, Emory, Uppsala University and others for advancing this important research. @Zihai @OhioState @HopkinsMedicine @EmoryUniversity
🔗 Read more: doi.org/10.1038/s41586-025-0…
10
125
476
29,160
So many ways for an immune cell to kill (or not to kill) a #cancer cell! This is a nice review summarizing non-apoptotic regulated cell death pathways and their complex interactions with the antitumor #immune response. nature.com/articles/s41392-0…
1
119
401
Meet the first patient in the world to receive Tecelra, a groundbreaking engineered cell therapy for synovial #sarcoma. This is a powerful story of resilience and innovation—and I’m so proud of our team @MoffittNews for leading the way in this area!
moffitt.org/endeavor/archive…
10
52
396
19,812
Happy Anniversary Katie! I couldn’t have a more loving and supportive partner. 31 incredible years and the best is yet to come!
29
2
298
#ScienceSaturday
❓ Why do some cancers resist immunotherapy?
➡️ A recent study in Nature found that certain cancers can “trick” the body’s immune system. They do this by changing how cells in the bone marrow develop. These changes cause more immune cells called macrophages to form — but these macrophages actually block the immune system from attacking the tumor.
➡️ Lung cancers cause this change by stressing cells in a way that activates a protein called NRF2. This reprogramming creates macrophages that protect the tumor instead of fighting it.
➡️ The researchers found that blocking NRF2, through drugs or genetic changes, lowered these protective macrophages, boosted immune cell activity and made immunotherapy work better. This suggests a new way to improve treatments for cancers that usually resist immunotherapy.
🌟 Congratulations to senior author Miriam Merad of the Icahn School of Medicine at Mount Sinai, and collaborators at Institut Gustave Roussy, Harvard Medical School and others for advancing this critical work. @MiriamMerad @SinaiImmunol @IcahnMountSinai
7
79
320
25,362
The Hwu Lab mourns the loss of one of our own, Dr. Deb Silverman @deb_silverman, who was so courageous in the face of breast cancer at such a young age. I’m so happy Deb was able to receive her Ph.D. and that she could visit from @MDAndersonNews to join our last lab team outing.
23
21
279
About 1/3 of all cancers diagnosed annually can be prevented, and more can be cured by early detection through screening. Do you know what #cancer screenings you should get? Check out the recommended screenings and prioritize your health this New Year! moffitt.org/endeavor/archive…
20
63
283
42,327
(1/2) Immune response against #cancer can be inhibited by myeloid derived suppressor cells (MDSCs). Defining and studying MDSCs has been challenging due to the lack of specific surface markers. science.org/doi/10.1126/scii…
2
57
247
So sad to hear about the passing of Jeff Weber, a giant in the field of oncology. He was involved in the early days of cytokine and cell therapy and most recently led studies of personalized vaccines for melanoma patients. I originally worked with Jeff @theNCI over 30 years ago. He was a great friend and colleague to many of us in the melanoma and immunotherapy field and we will remember him as a pioneer, thought leader and compassionate physician.
@sitcancer @DrJamesMule @BernardAFox
12
42
250
40,001
I've officially surpassed my first 100 days @MoffittNews and thought it was time to get connected to the world in a new way on Twitter. I'm looking forward to inspiration, collaboration and conversation. More on why I've joined moffitt.org/endeavor/archive…
23
24
230
It’s only appropriate that every few years our anniversary lands on #Thanksgiving. Grateful for 32 incredible years together and the best is yet to come! Happy Anniversary to my wife, Katie!
19
3
230
14,907
It was an honor to attend The @WhiteHouse Holiday Reception last night. We appreciate the commitment and support of @POTUS and @FLOTUS for cancer prevention, screening and research and to eliminate disparities in #cancer outcomes.
10
11
216
15,731
#ScienceSaturday
For #immunotherapy to be effective, T cells need to effectively infiltrate tumors. In this preclinical study, low molecular weight heparin was found to enhance T cell infiltration and anti-tumor efficacy for both adoptive T cell therapy and immune checkpoint blockade tumor models. jitc.bmj.com/content/11/8/e0…
10
68
225
45,172
What makes cancers regrow after therapy? Many cancers initially respond well to treatment but then progress due to resistant “persister cells”. nature.com/articles/d41586-0…
3
57
200
Happy Father’s Day to all the dads out there! Fatherhood is a humbling and fulfilling role and I have such unconditional love for my two girls who are so creative, compassionate and authentic. #FathersDay
12
2
202
How it started vs. how it's going! I've learned a lot over the last 50+ years, but the most important lesson is this: Action is what matters. Worrying produces nothing. #TransformationTuesday
9
5
191
It is such an honor to have @FLOTUS Dr. Jill Biden and @NCIDirector Dr. Ned Sharpless visiting Moffitt Cancer Center today. We are thrilled to share the important work our teams are doing here @MoffittNews to prevent and treat cancer. wfla.com/news/hillsborough-c…
5
28
187
Nothing beats a greeting from Maisy after being away at #ASCO22! 🐾
9
3
179
I was honored to be officially inducted as a Fellow in the National Academy of Inventors today in Washington, D.C.! The NAI Fellow program has more than 1,700 Fellows worldwide who collectively hold more than 58,000 issued U.S. patents. @AcadofInventors
32
4
174
7,778
Most of you know that our Bichon Frisé, Maisy, was a beloved member of our family. I am sad to share the news that Maisy passed away today, after a long and wonderful 16 years with the Hwu family. We will dearly miss her and the companionship and unconditional love she brought to our family.
50
170
24,275
#ScienceSaturday
Dendritic cells (DCs) play a critical role in activating CD4 and CD8 positive T cells to mediate the immune response against cancers.
❓But which DCs are the most important in triggering cancer-specific T cells?
➡️ In a recent report published in @SciImmunology, investigators utilized single cell spatial transcriptomic analysis to identify a relatively small population of DCs characterized by IL-27 production and a hyperactivated phenotype critical for activation of tumor-specific T cells, which was amplified with CTLA-4 immune checkpoint blockade.
➡️ Characterizing this important population of DCs may inform novel strategies to activate these DCs in #cancer patients to potentiate #immunotherapy responses.
🔗 Here’s a link to the full study- science.org/doi/10.1126/scii…
@victora_lab @ChudnovskiyLab
35
184
22,268
Just landed in D.C. Excited for the @sitcancer Annual Meeting this week! So glad we can all get together in person safely this year. #SITC21
2
1
171
#ScienceSaturday
❓ Why do some cancers resist anti-PD-1 immunotherapy?
➡️ A new study in @Nature shows that cancer-induced nerve injury (CINI) drives resistance. Tumors that damage nearby nerves trigger chronic inflammation, creating an immune-suppressive environment that blunts checkpoint blockade.
➡️ Importantly, targeting nerve injury pathways — such as blocking IL-6 signaling — helped restore response in models, pointing to new strategies to overcome resistance.
🌟 Congratulations to co-corresponding author Dr. Ken Tsai (@KYTsaiLab) of @MoffittNews, collaborators @MDAndersonNews and others for advancing this critical field.
🔗 Read more: doi.org/10.1038/s41586-025-0…
#CancerResearch #Immunotherapy #CheckpointBlockade #Neuroimmunology
3
40
165
12,156
Just landed in Boston for @sitcancer #SITC2022! We’re expecting 7,000 attendees, our largest SITC annual meeting ever! Hope to see you there!
5
10
152
Having a wonderful weekend with daughter Emily in Brooklyn, NY. Even got to see her perform with her band. She’s become quite the drummer in less than a year! #WeekendVibes
5
2
152
This hangs above my desk and is one of my major principles of #leadership. It’s by the ancient philosopher Lao Tsu. The best leaders are the ones who elevate others without them even knowing! #WednesdayWisdom
7
26
147
Epic practice last week with some new members of #TheRemissions and guest violinist Sen Lu, a @USFRadiology resident here @MoffittNews. #DancingQueen #behindthescenes
12
21
158
#ScienceSaturday
❓ How can we turn T-cells into cancer-fighting “soldiers” without changing their DNA?
➡️ A new study in Nature Biotechnology introduces an all-RNA platform that can turn T-cell genes on or off using epigenetic CRISPR tools called CRISPRoff and CRISPRon. Instead of cutting or rewriting DNA, this method “reprograms” genes by adding or removing chemical marks — allowing researchers to boost or silence key immune functions safely.
➡️ The team showed this can enhance CAR T-cell therapies, helping immune cells better recognize and attack tumors while reducing potential side effects linked to traditional gene editing.
🌟 Congratulations to senior authors Alex Marson, Luke Gilbert, Brian Shy, and Justin Eyquem of UCSF, Arc Institute, and Gladstone Institutes for this exciting advance — a big step toward the next generation of precise, safer immunotherapies.
🔗 Read more in Nature Biotechnology: doi.org/10.1038/s41587-025-0…
@LukeGilbertSF @UCSF @UCSFCancer @UCSFMedicine @arcinstitute @GladstoneInst @j_eyquem
1
39
153
9,276
Dr. Anirban Maitra is a treasured friend and colleague who is a leader in #pancreaticcancer research and has served as a mentor to many young investigators throughout the world! Go give him a follow @Aiims1742! #FollowFriday
7
18
144
12,672
#ScienceSaturday How can we identify tumor reactive T cells circulating in the blood? Using single cell transcriptomic profiling of tumor infiltrating lymphocytes (TIL) and blood lymphocytes, researchers at @NCI_CCR_SB identified a phenotypic signature of circulating T cells capable of recognizing mutated antigens. Interestingly, these circulating T cells appear to be more functional than those found in the tumor. This approach may provide an important alternative source of T cells for immunotherapy for #cancer.
Here’s a link to the full article: cell.com/cancer-cell/pdfExte…
6
35
142
29,554
Proud of myself. Got up in time for a pre-workday workout! Hope this is the start of a new trend.
6
140
8,077
Saddened by the loss of a member of the @MoffittNews family, Dr. Robert Gillies. Bob was a cherished member of the team who made remarkable strides in molecular imaging and cancer research. He will be greatly missed. Our thoughts are with his family, friends and peers.
12
22
132
Reflecting on the groundbreaking research of 2024 @MoffittNews!
From innovative treatments to breakthrough discoveries, we continue to push boundaries in cancer care. Excited for what’s to come in 2025. 🎉 moffitt.org/endeavor/archive…
9
18
137
71,476
Happy #FathersDay to all the dads out there! There really isn’t a better, more fulfilling job in the whole world!
4
2
141
4,013
#ScienceSaturday
The combination of anti-CTLA-4 and anti-PD-1 antibodies is FDA approved for the treatment of advanced #melanoma. How does this combination work mechanistically? In a recently published study in @Cancer_Cell using both single cell TCR and RNA sequencing, Wang et al demonstrate that the combination results in higher numbers of clonal T cells capable of recognizing melanoma and that anti-CTLA-4 drives the expansion of exhausted T cells while anti-PD-1 reinvigorates them. These insights may help with future patient selection as well as enhanced combinations and treatment schedules.
Here’s a link to the full study- cell.com/cancer-cell/abstrac…
5
25
139
16,973
#ScienceSaturday Mutations in cancer cells look “foreign” to the immune system and are excellent targets for T-cells. However, patients with high levels of mutations in their cancers don’t always respond durably to #immunotherapy. @PeterMKWestcott, @LabJacks et al demonstrate that tumor heterogeneity may be the issue, and that mutations that are only in a small population of the #cancer cells (subclonal) are not as correlated with clinical responses compared to mutations that are in all the cancer cells within a tumor (clonal). nature.com/articles/s41588-0…
2
30
131
28,992
Snow Patrol, a Scottish and Irish alternative rock band, had their biggest hit with the release of "Chasing Cars" in 2006. It has since been used in countless movies, TV shows and more. Had a great time covering it with #TheReMissions @MoffittNews last week! #MusicMonday 🤘
17
16
125
16,927
Can you travel from Tampa to NYC and back in the same day? So glad I was able to watch daughter Emily’s band perform in Brooklyn today. She’s become quite the accomplished drummer!
5
1
130
#ScienceSaturday Can dietary nutrients help the immune system kill #cancer cells? In this study, researchers screened 255 circulating nutrients for the ability to enhance T cell activity and found that the long-chain fatty acid TVA (Trans-vaccenic acid) could enhance the activity of CD8-positive “killer” T cells against cancer. This impressive work has significant implications for cancer #immunotherapy and beyond.
Here’s a link to the full article. nature.com/articles/s41586-0…
2
32
133
27,907
#ScienceSaturday CD8+ T cells classically kill tumor cells by recognition of peptide antigens in the context of class I MHC molecules, and downregulation or loss of class I expression can lead to tumor escape. @EmilyCLerner et al have now shown that CD8+ T cells can kill class I negative tumor cells through the receptor NKG2D, paving the way for strategies to neutralize this escape mechanism.
nature.com/articles/s43018-0…
4
26
133
22,879
Always a treasured day when you can spend it with your daughter! Great time in Central Park.
P.S. You’re never too old to ride a carousel!
9
1
131
Had a blast rocking out with #TheCheckPoints at the @sitcancer Annual Meeting last night! Did you enjoy the party?🤘🎹 #SITC22 @JimAllisonPhD @jasonlukemd @BReinfeld @RPachynski @FerranPrat5 @DocsWhoRock
2
12
126
Who knew that our Chair of Radiation Oncology, @KOSJ12, could sing like this?
Fun fact, the piano I’m playing on is the one I grew up playing — it’s over 50 years old!
14
8
127
14,721
If you look at the data, it's not the ratio of doctors to patients that's correlated with survival, it's the ratio of nurses to patients. That speaks volumes. I can't thank ours enough for their dedication and commitment to our number one priority, our patients. #NursesWeek
3
30
121
Cancer care isn't what it was 10 or even 5 years ago. Hospital leaders shouldn't ask if outpatient treatment with immune and cell-based therapies will become standard, but when.
Thanks, @BeckersHR, for the opportunity to share my perspective!
beckershospitalreview.com/on…
8
27
130
17,110
A virus to treat cancer? It's possible! In this week's #MoffittMedicalMinute I discuss #Oncolytic Virus Therapy!
7
25
112
The future of #cancer vaccines is bright! An important consideration is the type of antigen used in the vaccine. This review nicely summarizes the different types of antigens that are being investigated for #CancerVaccines. nature.com/articles/s43018-0…
4
27
114
Merry Christmas Eve to all my friends, family and colleagues who celebrate! #FeelingFestive #ChristmasEve
10
1
118
#ScienceSaturday
❓ Why do some patients respond better to immunotherapy?
➡️ A new study in Nature found that tumors with mutations in PPP2R1A — a gene encoding a scaffold protein in the PP2A complex — were linked to much longer survival after immune checkpoint blockade (ICB).
➡️ In ovarian clear cell carcinoma and other cancers, PPP2R1A mutations were tied to stronger immune signals, more tumor-infiltrating T cells, and better tumor control. Preclinical models confirmed that altering or inhibiting PPP2R1A boosted the effectiveness of ICB and CAR-T therapies.
🌟 These findings suggest PPP2R1A mutations could serve as a predictive biomarker for immunotherapy success and highlight PP2A as a potential therapeutic target to make treatments more effective.
🔗 Read more in @Nature: doi.org/10.1038/s41586-025-0…
@NaturePortfolio
@MDAndersonNews
#CancerResearch #Immunotherapy #Biomarkers #OvarianCancer #CheckpointBlockade
Thank you, @AmirJazaeri for your visit and lecture @MoffittNews this week!
5
43
128
12,444
#ScienceSaturday
The combination of anti-LAG-3 and anti-PD1 antibodies is @US_FDA approved for patients with advanced #melanoma. But how is this combination working mechanistically? In a recent issue of @CellCellPress, 3 manuscripts shed light and suggest that PD-1 blockade enhances T-cell proliferation while LAG-3 blockade enhances anti-tumor effector functions including cytotoxicity, cytokine production, and expression of activating NK receptors.
➡️ These insights may lead to the optimization of future therapeutic combinations for patients.
Here are links to the 3 articles as well as an excellent overview:
🔗 cell.com/cell/abstract/S0092…
🔗 cell.com/cell/abstract/S0092…
🔗 cell.com/cell/abstract/S0092…
🔗 cell.com/cell/abstract/S0092…
4
31
121
15,492
#ScienceSaturday
➡️ Immunotherapies targeting neoantigens can be effective in mediating long-term durable responses in advanced cancer patients. However, identifying these neoantigens from metastatic tumors can be logistically challenging.
🧬 In this study, investigators looked at whether archived, preserved primary tumor samples could be used for neoantigen discovery.
➡️ The study found that primary FFPE tumor samples could be used to discover most of the neoantigens present in metastatic tumors and even unique neoantigens not present in metastatic tumors.
🌟 This approach would reduce the need for additional, sometimes complicated resections and expedite the time to treatment! These promising findings could pave the way for more accessible and personalized therapies.
🔗Here's the link to the full study: jitc.bmj.com/content/13/1/e0…
@NCICCR_SurgOnc @theNCI @jitcancer
3
41
123
14,328
Everyone knows that we have bacteria in our gut, but did you know that #cancer cells can be infected with #bacteria and this can suppress the immune response against them?science.org/content/article/…
4
24
113
So wonderful to have the family all together over the holidays. Sending love and light from our family to yours!
5
2
114
8,814
Please join me in welcoming @karenluMD to @MoffittNews as our new Physician in Chief!
We are grateful to have a nationally recognized physician-scientist of Dr. Lu’s caliber coming onboard to lead our Moffitt Medical Group.
Welcome, Karen Lu, MD (@karenlumd), who will join Moffitt as our new Physician in Chief in June.
She has a proven track record of successfully leading clinical and translational teams, and we could not be more excited for her to join Moffitt at such a transformative time.
Please give Dr. Lu a very warm welcome.
Learn more about Dr. Lu: bit.ly/3ucLdKJ
10
8
111
11,798
Food is medicine! So proud to be part of this work led by @JenWargoMD, @CSpencerPhD, and @mcquadeMDLAc demonstrating that dietary fiber can alter the gut #microbiome and enhance the antitumor immune response in #melanoma patients. science.org/doi/10.1126/scie…
1
33
113
The Rosenberg group has characterized RNA signatures of T cells in the tumor that recognize cancers. This may help in identifying immune cells and receptors that can be used for patient therapy and will help us understand the tumor immune microenvironment. science.org/doi/10.1126/scie…
23
113
So fortunate that my girls have the most caring, loving and supportive mother in the world. Happy Mother’s Day to all the moms out there! #MothersDay
7
2
115
4,549
The Moffitt Cancer Center "M" has officially been hoisted and positioned at the top of our new McKinley hospital. A sure sign of the incredible progress toward our opening this July! @MoffittNews
2
6
112
8,112
Also had the opportunity to meet former pro tennis star @Martina Navratilova at the @RepDWStweets Cancer Survivorship Summit, who was speaking on The Caregiver Experience.
5
4
99
10,575
Our @Moffittnews Physician in Chief, @KarenLuMD, has hit the ground running and been an extraordinary leader. Learn more about her work as a nationally recognized physician-scientist and her goals at Moffitt! moffitt.org/endeavor/archive…
7
18
109
46,167
Moffitt awarded $10.2 million grant from @theNCI to support team research focused on investigating lung cancer metabolism to help develop new therapies. Congrats @LabElsaFlores and team! moffitt.org/newsroom/press-r…
1
6
109
Honoring and remembering my former student, Dr. Deb Silverman, at @ACSCAN's 13th Annual Lights of Hope event in D.C. tonight. Our work continues for the patients of today, the patients of tomorrow and those taken too soon. 🕯💙 #MoffittDCFlyIn #LightsofHope @deb_silverman
5
14
106
8,481
Had so much fun practicing with The CheckPoints last night getting ready for our Sunday concert at #AACR24!
@sitcancer @FerranPrat5 @RPachynski @BReinfeld @jasonlukemd @JimAllisonPhD @PamSharmaMDPhD @AACR
1
9
108
9,176
Honored to kick off our @MoffittNews 2022 #MilesforMoffitt event on this beautiful, chilly morning in Downtown Tampa!
3
12
101
Behind the scenes filming the band's rooftop music video. And the perfect time to announce our band name (drumroll, please...) "The Remissions!" Now for logo design ... 🤘 🎹 🎤 🎸
3
13
99
Dr. Dana Ataya is a subspecialty-trained breast radiologist, educator and researcher @MoffittNews. She’s also the rockstar lead vocalist in our band, #TheReMissions! Go give her a follow @DanaAtayaMD! #FollowFriday
7
9
102
12,745
Today is #GlobalHandwashingDay, and Moffitt’s band, #TheReMissions, is delivering an important message! 🧼👏
Researchers estimate that if everyone routinely washed their hands, 1 million deaths a year could be prevented! #CleanHandsAreWithinReach #DocsWhoRock @DocsWhoRock
73
22
94
80,551
As @SITCancer President, it was an honor to induct our first class of Fellows of the Academy of Immuno-Oncology (FAIO) last night. These impressive individuals helped get us where we are today, and mentored many of the leaders in the field. #SITC21 sitcancer.org/funding/awards…
11
103
LIVE from #TheCheckPoints Party at #SITC24! 🎶 Here’s a behind-the-scenes look at us performing "Walking on Sunshine." So proud to be part of the @sitcancer band, playing to support early-career scientists!
4
6
103
9,021
So proud of Ally for her graduation from @ChapmanU this weekend! She’s demonstrated such determination and resilience over the past four years! #ProudDadMoment
14
2
105
5,253
We're just getting warmed up, Chicago! #TheCheckPoints are back in action practicing for our annual #ASCO24 gig @BuddyGuys this Sunday evening! 🎶
@sitcancer @FerranPrat5 @RPachynski @BReinfeld @jasonlukemd @JimAllisonPhD @PamSharmaMDPhD @wolchokj
21
95
9,048
Small molecule STING agonists can trigger innate immune cells which can lead to potent T-cell mediated antitumor immune responses. @NatalieArtzi and colleagues recently demonstrated that nanoparticle conjugation can enhance the antitumor potency of intravenously administered STING agonists by increasing half-life and stability. This has important translational potential for combination immunotherapies in #cancer patients. #ScienceSaturday nature.com/articles/s41565-0…
23
99
16,937
#ScienceSaturday
➡️ T cells in the tumor microenvironment can become exhausted, limiting their ability to kill cancer cells.
❓ How can we prevent T cell exhaustion?
➡️ In a recent study, Ma et al found that the protein P4HA1 accumulated in activated CD8 T cells, interfering with mitochondrial function and promoting T cell exhaustion. Targeting P4HA1 improved T cell expansion, decreased exhaustion and improved antitumor responses in preclinical models.
🌟 This represents a promising approach to one day enhance T cell therapy in patients.
🔗 Here’s a link to the full study: cell.com/cancer-cell/abstrac…
@Cancer_Cell
2
23
101
9,292
The Cranberries have always been one of my favorite bands. Here’s our version of “Dreams.” I love the harmonies between Dana, Shelley and Mark on this. #TheReMissions #BandPractice #DocsWhoRock @DocsWhoRock
12
12
96
5,526
Ran into our hard working Environmental Services team preparing for #HurricaneIan by removing potential projectiles around campus. Our @MoffittNews team is well prepared to weather the storm! Please stay safe.
8
3
94
Nothing better than jamming with my daughter Ally. Played "You’ve Got a Friend" together while visiting her in Cali! Always love making music together. #MusicMonday #FamilyTime #FatherDaughter #YouveGotAFriend
8
2
99
5,249
Excited to be back with @SITCancer’s house band, #TheCheckPoints, on the West Coast performing for our friends and colleagues during @AACR's annual meeting! #AACR24
@FerranPrat5 @RPachynski @BReinfeld @jasonlukemd @JimAllisonPhD @PamSharmaMDPhD @Wolchokj
8
8
97
6,358
What an incredible ride it's been at #SITC23. It's true, California knows how to party! #TheCheckPoints hit the waves tonight for a special "Surfing for a Cure" event. Together, we're riding the tide towards a future without cancer. @SITCANCER
2
15
89
8,192
We just recently got my lab up and running here @MoffittNews! Come along with me for a video tour. #immunotherapy #TCells #cellularimmunotherapy #melanoma #cancerresearch
"What people may not know about me is that I'm an immunologist, and I've had a lab for over 30 years."
Come along for a video tour of @MoffittNews president and CEO @PatrickHwuMD's lab! 🔬
2
6
89
#ScienceSaturday
❓ Can engineered T cells target the mutations that cause cancer to eliminate solid tumors?
➡️ In a new study, @JOlweus and colleagues found that a common β-catenin driver mutation (CTNNB1-S37F) creates new “flags” (peptides) on cancer cells that the immune system can see.
➡️ Researchers built T cells with custom receptors (TCRs) that recognize these mutant flags. In lab and animal models, the engineered T cells completely wiped out tumors.
➡️ Because this mutation appears in thousands of new cancer cases each year in the U.S., it could become a powerful shared immunotherapy target.
🌟 This is a promising step toward harnessing “public” mutations as broad cancer treatments.
🔗 Read the full study in @NatImmunol: nature.com/articles/s41590-0…
@CoE_PRIMA
28
99
7,325
Thrilled Moffitt Cancer Center has once again been named the #1 Cancer Hospital in Florida and the Southeast by @Newsweek. @MoffittNews has also been recognized on Newsweek’s list of the World's Best Oncology Hospitals. These recognitions are a testament to the quality of research, care and exceptional outcomes provided.
Congratulations, team!
4
21
94
3,717
My favorite way to unwind after a day of work is music, of course! What’s yours? #NationalRelaxationDay
7
1
92
Just landed in San Diego! Looking forward to an exciting week at the @sitcancer annual meeting and pre-program workshops! #SITC23
Also excited to be reunited with #TheCheckPoints for our West Coast concert on Saturday!
2
5
89
3,323
Happy National Doctors’ Day! Thank you to all of our incredible doctors @MoffittNews who dedicate so much to our patients and our mission. #NationalDoctorsDay
11
14
91
6,869
Congratulations to Dr. Ana Gomes (@Lab_Gomes) on receiving the @NIH New Innovator Award! This marks the first time a Moffitt faculty member has received this award and demonstrates the exceptional research of Dr. Gomes on aging and cancer development. moffitt.org/newsroom/press-r…
5
11
89
The people have spoken ... and they want to hear #TheReMissions. Happy #MusicMonday. Enjoy our rendition of 'Ain't No Sunshine' on this cloudy Florida day. @DocWhoRock #NursesWhoRock
Vocals: @DanaAtayaMD
Bass: @JeffLeightonRN
Guitar: @DrJamesMule
Drums: @RonnyZ85728502
20
22
93
👨👩👧👧#FathersDay reflections...
So grateful to be a father to my two girls, Emily and Ally. Both bring such bright light to the world around them, and it's so fulfilling to see what compassionate young women they have become. 💕
Happy Father's Day!
4
1
95
2,553
Dr. Aung Naing is a very talented phase I and #immunotherapy investigator who I have had the pleasure to work with for many years, and I'm so proud of all his accomplishments! Go give him a follow @ANaingMD! #FollowFriday
@MDAndersonNews @sitcancer @gulleyj1
6
21
84
15,261
Happy to catch up with my good friend Anirban Maitra @Aiims1742, who is an authority on #PancreaticCancer and my Twitter role model!😄 #SU2CSummit2023 @SU2C
1
2
90
4,143
What a memorable night performing with The CheckPoints and celebrating our collective strides in cancer #immunotherapy @BuddyGuys! @sitcancer #ASCO23 #MoffittASCO23 #MusicMonday
6
9
83
7,294
It was an honor to have dinner this evening with our @MoffittNews founder @HLeeMoffitt1!
3
5
92
4,352
Always great to catch up with our incredible founder Lee Moffitt. We owe so much to his visionary leadership! @HLeeMoffitt1 @MoffittNews
2
4
94
4,841
#ScienceSaturday
Better treatments are needed when cancers spread to the brain, which can especially happen in #melanoma, lung and breast #cancer. The secret may lie in the blood vessels of these brain metastases. @BejaranoLeire, @Johanna_A_Joyce and colleagues performed an extensive molecular analysis of human and murine brain metastases and found a number of potential targets, including CD276 (B7-H3), that when blocked could increase the infiltration of cytotoxic CD8 positive T cells into brain mets and decrease tumor growth in preclinical models.
Here’s a link to the full study- cell.com/cancer-cell/fulltex…
2
28
91
11,611